Harvard Bioscience
HBIO
#10554
Rank
A$52.04 M
Marketcap
A$11.43
Share price
-0.37%
Change (1 day)
1,573.45%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -A$14.71 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are A$85.53 Million. In 2025 the company made an earning of -A$81.81 Million a decrease over its 2024 earnings that were of -A$16.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$14.71 Million-82.03%
2025 -A$81.81 Million391.95%
2024 -A$16.63 Million356.38%
2023 -A$3.65 Million-72.15%
2022 -A$13.09 Million6456.43%
2021 -A$0.2 Million-98.08%
2020 -A$10.4 Million32.53%
2019 -A$7.85 Million-31.01%
2018 -A$11.37 Million243.9%
2017 -A$3.31 Million-24.66%
2016 -A$4.39 Million-14.69%
2015 -A$5.15 Million-181.68%
2014 A$6.29 M-9.97%
2013 A$6.99 M120%
2012 A$3.17 M-50.9%
2011 A$6.47 M-52.51%
2010 A$13.63 M-2.53%
2009 A$13.98 M28.26%
2008 A$10.9 M-20.05%
2007 A$13.63 M13.96%
2006 A$11.96 M17.59%
2005 A$10.17 M57.37%
2004 A$6.46 M-37.31%
2003 A$10.31 M208.03%
2002 A$3.34 M-168.71%
2001 -A$4.88 Million-66.89%
2000 -A$14.72 Million